ISCIII

Health Institute Carlos III

Information
Avenida Monforte de Lemos, 5. 28029, Madrid.

pollution, covid-19, rare diseases, epidemiology, immunology, microbiology, AIDS / HIV
Contact
José A. Plaza
Head of Communications
ja.plaza@isciii.es
918227196 / 669187384

If you are the contact person for this centre and you wish to make any changes, please contact us.

SMC participants

Director of the National Centre for Tropical Medicine (CNMT) at the Carlos III Health Institute

PhD in Pharmacy, Professor of Human Physiology at the University of Navarra, member of the CIBER Physiopathology of Obesity, Carlos III Health Institute and IDISNA (Navarra)

Head of the Influenza and other Respiratory Virus Surveillance Group of the National Epidemiology Centre.

Researcher at the Reference and Research Laboratory in Mycology, National Microbiology Centre, Instituto de Salud Carlos III

Senior Scientist at the Health Institute Carlos III

HIV, STI and hepatitis B and C Surveillance Unit. National Centre of Epidemiology, Health Institute Carlos III

Researcher in social epidemiology, public health and biostatistics 

Researcher with a PhD employed at the National Epidemiology Centre of the Carlos III Health Institute (ISCIII)

Research scientist and member of the Department of Climate Change, Health and the Urban Environment at the Carlos III Health Institute

Researcher at the Mortality Monitoring System (MoMo) at the National Centre for Epidemiology of the Carlos III Health Institute

Senior Scientist at the Special Pathogens Research and Reference Laboratory of the National Microbiology Centre of the Carlos III Health Institute

Director and Research Scientist at the Institute for Rare Diseases Research (IIER), Carlos III Health Institute (ISCIII)

 

Researcher at the National Center for Microbiology - Carlos III Health Institute

Senior scientist at the Reference Laboratory for Influenza and Respiratory Viruses of the National Microbiology Centre.

Scientific researcher at the National Epidemiology Centre - Carlos III Institute of Health

 

Head of the Respiratory Virus and Influenza Research Group of the Carlos III Health Institute

Full professor of Pathological Anatomy at the University of Oviedo, Scientific Director of the Principality of Asturias Biobank (BioPA) and Coordinator of the Organoid hub of the ISCIII Biomodels and Biobanks platform

Senior Scientist, Immunology Laboratory, Carlos III Health Institute

Research Professor at IDIBAPS-Hospital Clínic de Barcelona and Scientific Director of CIBEREHD - Carlos III Health Institute

Researcher in Vaccine-Preventable Disease Epidemiology at the National Centre of Epidemiology of the Health Institute Carlos III and member of CIBERESP

Scientific researcher at the Reference and Research Laboratory for Immunopreventable Viral Diseases of the National Microbiology Centre - Carlos III Health Institute

Research professor and member of the Departament on Climate Change, Health and the Urban Environment at the Carlos III Health Institute

Senior Researcher, Head of the Enterovirus and Viral Gastroenteritis Unit (Reference and Research Laboratory for Immunopreventable Viral Diseases), Centro Nacional de Microbiología, Instituto de Salud Carlos III

Head of the Central Scientific-Technical Units and Head of the Veterinary Unit of the Carlos III Health Institute

Head of the National Reference Laboratory for Gastroenteritis-Producing Viruses of the National Microbiology Centre - Carlos III Health Institute

Postdoctoral researcher at the Instituto de Investigaciones Raras Health Institute Carlos III

Virologist at the Reference Laboratory for Influenza and Respiratory Viruses of the National Microbiology Centre - Carlos III Health Institute

Cancer epidemiologist and Director General of the Carlos III Health Institute

Researcher at the National Epidemiology Centre of the Carlos III Health Institute, Associate Professor of Preventive Medicine and Public Health at the University of Alcalá.

Researcher at the National Epidemiology Centre (CNE-ISCIII)

Scientific researcher at the Cancer and Environmental Epidemiology Unit of the National Epidemiology Centre, Carlos III Health Institute, member of CIBERESP and co-coordinator of the Cancer Epidemiological Surveillance Sub-programme - VICA of CIBERESP

Senior Researcher at the Carlos III Health Institute, Head of the Neuro-oncology Unit at the Chronic Diseases Research Unit (UFIEC-ISCIII)

ICREA Research Professor, Director of Andero Lab and the Rodent Behavioral Core at the Autonomous University of Barcelona (UAB), and researcher in the Department of Psychobiology and Methodology of Health Sciences at the UAB and at the Carlos III Health Institute, CIBERSAM

Assistant Professor in the Department of Preventive Medicine and Public Health at the University of Valencia, and researcher at the CIBER Centre for the Physiopathology of Obesity and Nutrition (CIBEROBN) at the Carlos III Institute

Researcher at the Reference Laboratory for Influenza and Respiratory Viruses at the Centro Nacional de Microbiología - Instituto de Salud Carlos III

Medical Epidemiologist at the National Epidemiology Centre - Carlos III Health Institute

Researcher in the Viral Biology laboratory of the Carlos III Health Institute

Senior Scientist at the Carlos III Health Institute, in the area of ​​Environmental Toxicology of the National Center for Environmental Health

HIV, STI and hepatitis B and C Surveillance Unit. National Centre of Epidemiology, Health Institute Carlos III

Contents related to this centre
gripe_aviar

Although outbreaks of H5N1 avian influenza have reached record numbers in recent years, human infections remain anecdotal. A study published today in Nature identifies a protein responsible for inhibiting the replication of this virus in humans, while 'human' flus are able to evade it. The authors propose that this protein with antiviral activity evolved in primates and consider that resistance or sensitivity to it should be taken into account when assessing the zoonotic potential of avian influenza viruses.

baby

On 5 April, the UK National IHR Focal Point informed WHO of an increase in severe myocarditis in neonates associated with enterovirus infection in Wales (UK). Between June 2022 and April 2023, ten hospitalised neonates with a positive PCR for enterovirus were found to have myocarditis. Seven of the ten cases were confirmed to have coxsackievirus B3 or coxsackievirus B4. As of 5 May 2023, one patient remained hospitalised and one patient had died. According to the WHO statement, although enterovirus infections are common in neonates and infants, the reported increase in myocarditis - inflammation of heart muscle tissue - with severe outcome associated with enterovirus infection is unusual.

mouse

A drug in gel form cured 100 percent of mice with a very aggressive brain tumor. The authors hope that this is a first step towards helping human patients with glioblastoma, one of the most dangerous brain tumors in humans. The article is published today in PNAS.

flu vaccine

A study published in the journal Science Translational Medicine shows the results of a phase 1 trial of a new broad-spectrum influenza vaccine. Prepared in the form of nanoparticles containing the H1 hemagglutinin stem-a region that is often conserved in different subtypes of the virus-the vaccine was generally well tolerated by participants, who showed only mild side effects such as tenderness and headaches. The prototype generated an antibody response to group 1 influenza viruses in all age groups.

glioma

Between 10-15% of childhood brain tumours are diffuse midline gliomas, a type of tumour that occurs within the brainstem, making it almost impossible to remove surgically. Research published in Science Translational Medicine has used a type of molecule (antisense-ASO oligonucleotides) in mouse models of this tumour to slow tumour growth and prolong survival. The authors hope that the research will reach clinical trials and, in that case, the potential new treatment would be combined with others such as radiotherapy or immunotherapy with CAR-T cells.

pollution

An international group of researchers has conducted an epidemiological study to investigate the correlation between fine particulate matter (PM2.5) air pollution and certain types of lung cancer. The authors have confirmed their findings in animal models, according to research published in Nature.

HIV

A study published in the journal Cell shares the case of the "New York patient", a woman with leukaemia and HIV who identifies as "mixed race" and has been free of the virus since 2017. She would be the first woman to be cured of the virus after a bone marrow transplant and there are now four such cases, along with patients in Düsseldorf, Berlin and London. The method involves transplanting HIV-resistant stem cells, this time from umbilical cord blood.

Tobacco and lung cancer

Un estudio ha estimado las muertes por cáncer que se producirán en la Unión Europea y el Reino Unido en 2023. Comparándolas con las observadas en 2018, estiman que se reducirán en un 6,5 % en hombres y un 3,7 % en mujeres de forma global. Sin embargo, en España aumentará la mortalidad por cáncer de pulmón en mujeres. Los resultados se publican en la revista Annals of Oncology. 

Aedes

The Centre for the Coordination of Alerts and Health Emergencies (CCAES) reported yesterday that last February Germany reported two cases of dengue (one confirmed and one probable), along with four cases compatible with epidemiological links, in residents of Germany who had travelled to Ibiza during the incubation period. One of the potential vectors of dengue is the Aedes albopictus mosquito, which was first detected in Ibiza in 2014. According to the CCAES, the risk of new autochthonous cases appearing in Ibiza, "at this time of low vector activity, is considered low".

noonan

Every February 28 or 29, World Rare Disease Day is celebrated, an initiative that aims to raise awareness about rare diseases in order to improve access to diagnosis and treatment and achieve a better quality of life among those who suffer from them. Here are some frequently asked questions about the most important concepts, their current situation and the main complaints that affected individuals and families continue to have.